Brief: IGC Reports Issuance Of Patent For Treatment Of Alzheimer’s Using THC
21/09/2022 11:26
Sept 21 (Reuters) - India Globalization Capital Inc IGC.A :
* IGC ANNOUNCES ISSUANCE OF SECOND PATENT FOR THE TREATMENT
OF
ALZHEIMER’S USING THC
Source text for Eikon: ID:nBw4lXCTGa
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment